Itron, Inc. (NASDAQ:ITRI – Get Free Report) SVP Christopher Ware sold 189 shares of the business’s stock in a transaction dated Wednesday, May 20th. The shares were sold at an average price of $79.60, for a total transaction of $15,044.40. Following the transaction, the senior vice president directly owned 30,506 shares in the company, valued at approximately $2,428,277.60. The trade was a 0.62% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Itron Trading Up 0.6%
Shares of ITRI stock opened at $81.85 on Friday. The company’s 50-day moving average price is $88.63 and its 200-day moving average price is $94.60. The company has a current ratio of 2.66, a quick ratio of 2.24 and a debt-to-equity ratio of 0.97. The stock has a market cap of $3.63 billion, a price-to-earnings ratio of 13.05, a PEG ratio of 0.71 and a beta of 1.35. Itron, Inc. has a twelve month low of $77.77 and a twelve month high of $142.00.
Itron (NASDAQ:ITRI – Get Free Report) last announced its quarterly earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.23. The firm had revenue of $586.98 million for the quarter, compared to analysts’ expectations of $572.04 million. Itron had a net margin of 12.31% and a return on equity of 19.54%. The company’s revenue was down 3.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.52 EPS. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. As a group, equities analysts predict that Itron, Inc. will post 6.01 earnings per share for the current year.
Itron News Summary
- Positive Sentiment: Stephens reaffirmed its Overweight rating on Itron and kept a $130 price target, implying substantial upside from the current share price. Stephens reaffirms Overweight on Itron
- Neutral Sentiment: Several Itron executives sold small blocks of shares, but the filings say the transactions were mainly to cover tax withholding from equity award vesting, which makes the insider activity less concerning than open-market selling. SEC filing for insider sale
- Negative Sentiment: Zacks Research cut multiple earnings estimates for Itron, including a sharp reduction for Q4 2027 and a lower FY2027 forecast, signaling softer profit expectations ahead. Zacks Research estimate cuts for Itron
Institutional Investors Weigh In On Itron
Large investors have recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in shares of Itron by 2.3% during the third quarter. Vanguard Group Inc. now owns 5,875,153 shares of the scientific and technical instruments company’s stock worth $731,809,000 after purchasing an additional 132,329 shares during the period. Impax Asset Management Group plc lifted its holdings in shares of Itron by 127.3% during the third quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock worth $197,153,000 after purchasing an additional 890,040 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of Itron by 20.9% during the first quarter. Dimensional Fund Advisors LP now owns 1,536,081 shares of the scientific and technical instruments company’s stock worth $137,659,000 after purchasing an additional 265,039 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Itron by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 1,144,982 shares of the scientific and technical instruments company’s stock worth $106,340,000 after purchasing an additional 6,598 shares during the period. Finally, Handelsbanken Fonder AB lifted its holdings in shares of Itron by 6.0% during the third quarter. Handelsbanken Fonder AB now owns 999,882 shares of the scientific and technical instruments company’s stock worth $124,545,000 after purchasing an additional 56,318 shares during the period. 96.19% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of analysts have issued reports on ITRI shares. TD Cowen cut their price target on shares of Itron from $145.00 to $130.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. Guggenheim set a $155.00 target price on shares of Itron in a research note on Friday, February 13th. Oppenheimer upped their target price on shares of Itron from $133.00 to $135.00 and gave the stock an “outperform” rating in a research note on Thursday, April 16th. Robert W. Baird set a $128.00 target price on shares of Itron and gave the stock an “outperform” rating in a research note on Wednesday, February 18th. Finally, JPMorgan Chase & Co. cut their target price on shares of Itron from $133.00 to $113.00 and set an “overweight” rating on the stock in a research note on Thursday, April 16th. Eight research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Itron has a consensus rating of “Moderate Buy” and a consensus price target of $131.22.
View Our Latest Analysis on ITRI
About Itron
Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.
Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.
Featured Articles
- Five stocks we like better than Itron
- Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half
- Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
- Intuit’s Great SaaS Reset: Fired By AI
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.
